ArticleBiomolecules2026
Glycoproteomics and Functional Characterization of Novel Variants in Siblings with ALG1-CDG.
Dongzhi Wei, Hui Wang, Senlin Peng, Yu Huang, Ganglong Yang, Weijie Dong, Xiaodong Gao, Ning Wang
Abstract read
In one paragraphArticle in Biomolecules, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Dongzhi WeiState Key Laboratory of Biopharmaceutical Preparation and Delivery, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, China.
Hui WangState Key Laboratory of Biopharmaceutical Preparation and Delivery, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, China.
Senlin PengState Key Laboratory of Biopharmaceutical Preparation and Delivery, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, China.
Yu HuangDepartment of Medical Genetics, School of Basic Medical Sciences, Peking University, Beijing 100191, China.
Ganglong YangState Key Laboratory of Biopharmaceutical Preparation and Delivery, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, China.
Xiaodong GaoState Key Laboratory of Biopharmaceutical Preparation and Delivery, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, China.ORCID 0000-0002-8575-5095 Ning WangState Key Laboratory of Biopharmaceutical Preparation and Delivery, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, China.
Funding
Beijing Natural Science Foundation 2242022National Natural Science Foundation of China 22077053National Natural Science Foundation of China 32271342Postgraduate Research & Practice Innovation Program of Jiangsu Province KYCX23_2568Strategy Priority Research Program (Category C) of Chinese Academy of Sciences XDC0290302
6 · The paper itselfAbstract
Congenital disorders of glycosylation (CDGs) are a growing group of inborn errors caused by gene defects in glycan biosynthesis pathways. Genetic testing of two patients from the same family harboring
Indexed as
Congenital Disorders of GlycosylationMannosyltransferasesProteomicsAmino Acid SequenceFemaleGlycosylationHumansMaleSiblingsTransferrinchitobiosyldiphosphodolichol beta-mannosyltransferaseMannosyltransferasesTransferrinALG1congenital disorders of glycosylationglycoproteomicsmolecular basissplicing variant
Identifiers
PMID42793140
PMCPMC13604089
What OpenQuestion holds
Textmetadata
Read underepoch 390